152 related articles for article (PubMed ID: 27409171)
1. Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis.
Liu CC; Wang H; Wang JH; Wang L; Geng QR; Chen XQ; Lu Y
Oncotarget; 2016 Aug; 7(34):55181-55190. PubMed ID: 27409171
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
[TBL] [Abstract][Full Text] [Related]
3. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
[TBL] [Abstract][Full Text] [Related]
4. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
Wang L; Liu P; Geng Q; Chen X; Lv Y
Leuk Lymphoma; 2011 Sep; 52(9):1697-703. PubMed ID: 21815777
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
[TBL] [Abstract][Full Text] [Related]
7. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Suh KJ; Keam B; Kim M; Park YS; Kim TM; Jeon YK; Kim DW; Chung DH; Kim YW; Heo DS
Clin Lung Cancer; 2016 Jul; 17(4):245-252.e1. PubMed ID: 26719155
[TBL] [Abstract][Full Text] [Related]
8. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Huang Z; Xu D; Zhang F; Ying Y; Song L
Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL).
Nakatsuka S; Nishiu M; Tomita Y; Miwa H; Takakuwa T; Iuchi K; Yamamoto S; Aozasa K
Jpn J Cancer Res; 2002 Apr; 93(4):411-6. PubMed ID: 11985791
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum].
Rowińska-Zakrzewska E; Szturmowicz M; Sakowicz A; Pawlicka L; Remiszewki P; Szopiński J; Wiatr E; Zych J
Pneumonol Alergol Pol; 1995; 63(11-12):601-8. PubMed ID: 8616474
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
12. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of neuron-specific enolase in head trauma patients.
Meric E; Gunduz A; Turedi S; Cakir E; Yandi M
J Emerg Med; 2010 Apr; 38(3):297-301. PubMed ID: 18499387
[TBL] [Abstract][Full Text] [Related]
14. Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response.
Nam SJ; Jeong JY; Jang TW; Jung MH; Chun BK; Cha HJ; Oak CH
Korean J Intern Med; 2016 Jul; 31(4):694-702. PubMed ID: 27271274
[TBL] [Abstract][Full Text] [Related]
15. Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation?
Honda K; Ohga S; Takada H; Nomura A; Ohshima K; Kinukawa N; Mizuno Y; Hara T
Int J Hematol; 2000 Jul; 72(1):55-60. PubMed ID: 10979210
[TBL] [Abstract][Full Text] [Related]
16. Clinical research on neuroblastoma based on serum lactate dehydrogenase.
Pang QM; Li K; Ma LJ; Sun RP
J Biol Regul Homeost Agents; 2015; 29(1):131-4. PubMed ID: 25864749
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
[TBL] [Abstract][Full Text] [Related]
18. Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema.
Li J; Yan M; Zhang Y; Xie M; Yan L; Chen J
Diabet Med; 2015 Jan; 32(1):102-7. PubMed ID: 25252158
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of serum neuron-specific enolase in non-small cell lung cancer].
Kimura H; Yamaguchi T; Nishino K; Nakagawa M; Yokota S; Nishikawa H; Ito M; Ogura T
Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):128-32. PubMed ID: 9617138
[TBL] [Abstract][Full Text] [Related]
20. [Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].
Zych J; Szturmowicz M; Sakowicz A; Słodkowska J; Załeska M; Radzikowska E; Załeska J; Jodkiewicz Z; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 2002; 70(5-6):278-83. PubMed ID: 12518626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
